Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited

Positive

AI Analysis

Summary

Piramal Pharma Limited completed its acquisition of a controlling stake in Yapan Bio Private Limited, a contract manufacturer specializing in process development, characterization, and GMP manufacturing services for vaccines and biologics. Piramal had previously held a stake in Yapan Bio since 2021.

Outcome Details

Completed acquisition of controlling stake in Yapan Bio Private Limited

Importance:6/10

Sentiment:

0.50

acquisitioncontrolling stakeGMP manufacturingvaccinesbiologicsprocess development

Read the original article

Published by PR Newswire Pharma on August 18, 2026 7:44 PM

Read Original